1. Home
  2. DRMA vs ONFO Comparison

DRMA vs ONFO Comparison

Compare DRMA & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • ONFO
  • Stock Information
  • Founded
  • DRMA 2014
  • ONFO 2018
  • Country
  • DRMA United States
  • ONFO United States
  • Employees
  • DRMA N/A
  • ONFO N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • ONFO Computer Software: Programming Data Processing
  • Sector
  • DRMA Health Care
  • ONFO Technology
  • Exchange
  • DRMA Nasdaq
  • ONFO Nasdaq
  • Market Cap
  • DRMA 6.1M
  • ONFO 6.2M
  • IPO Year
  • DRMA 2021
  • ONFO 2022
  • Fundamental
  • Price
  • DRMA $0.99
  • ONFO $0.93
  • Analyst Decision
  • DRMA Strong Buy
  • ONFO
  • Analyst Count
  • DRMA 1
  • ONFO 0
  • Target Price
  • DRMA $6.00
  • ONFO N/A
  • AVG Volume (30 Days)
  • DRMA 4.1M
  • ONFO 31.1K
  • Earning Date
  • DRMA 05-14-2025
  • ONFO 05-20-2025
  • Dividend Yield
  • DRMA N/A
  • ONFO N/A
  • EPS Growth
  • DRMA N/A
  • ONFO N/A
  • EPS
  • DRMA N/A
  • ONFO N/A
  • Revenue
  • DRMA N/A
  • ONFO $6,590,171.00
  • Revenue This Year
  • DRMA N/A
  • ONFO $133.59
  • Revenue Next Year
  • DRMA N/A
  • ONFO N/A
  • P/E Ratio
  • DRMA N/A
  • ONFO N/A
  • Revenue Growth
  • DRMA N/A
  • ONFO 29.25
  • 52 Week Low
  • DRMA $0.95
  • ONFO $0.39
  • 52 Week High
  • DRMA $6.66
  • ONFO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 35.86
  • ONFO 40.53
  • Support Level
  • DRMA $1.16
  • ONFO $0.61
  • Resistance Level
  • DRMA $2.37
  • ONFO $1.38
  • Average True Range (ATR)
  • DRMA 0.17
  • ONFO 0.11
  • MACD
  • DRMA -0.03
  • ONFO -0.03
  • Stochastic Oscillator
  • DRMA 2.86
  • ONFO 41.34

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.

Share on Social Networks: